+202.9%
MRNA vs ZYBT
-58.9%
+261.8%
-53.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ZYBT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -2.5% | +7.9% | +5.4% |
| 7D | -1.1% | -3.7% | +2.6% | -1.1% |
| 30D | +126.1% | 0.0% | +126.1% | +126.1% |
| 3M | +190.0% | +72.2% | +117.8% | +200.2% |
| 6M | +157.2% | +103.1% | +54.1% | +165.0% |
| YTD | +388.2% | +34.8% | +353.4% | +404.6% |
| 1Y | +467.0% | -83.2% | +550.2% | +496.7% |
| All | +202.9% | -58.9% | +261.8% | +195.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ZYBT.
Daily Out/Under-Performance
Portfolio return minus ZYBT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZYBT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ZYBT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling